Molecular docking studies were carried out to understand the mechanism of action of some 2-alkoxycarbonylallyl esters against pancreatic cancer (MiaPaCa-2) cell line targeting the epidermal growth factor receptor (EGFR). This evidence concerns the gene EGFR and pancreatic neoplasm.